OpenDoors is a dynamic pharmaceutical company, Portuguese market leader in API distribution, also with active sales in Spain, Greece, Algeria, and Morocco.
Currently collaborating with world-leading companies in licensing of innovative medicines, generics, OTCs, medical devices, and dietary supplements, associated with finished product supply contracts.
We offer Global expertise in In/Out Licensing agreements across the globe (currently 76 countries with signed contracts)
Company Details
- Employees
- 4
- Founded
- 2018
- Address
- Rua Professor Henrique De Barros N 4 - R/chão G, Edifício Sagres,portugal
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://opendoors.pt/
- Keywords
- generics, OTC, Medical Devices, food supplements, Medicines, Consulting, Food ingredients, Global in/out License, API, Active pharmaceutical ingredients, license and supply finished formulations, Import and export managemen, market entry.
- HQ
- Prior Velho, Lisboa
Opendoors Pharma Questions
Opendoors Pharma's website is https://opendoors.pt/
Opendoors Pharma's LinkedIn profile is https://pt.linkedin.com/company/opendoorspharma
Opendoors Pharma has
4 employees.
View email and phone details for 4
employees at Opendoors Pharma.
Opendoors Pharma's industry is
Pharmaceutical Manufacturing
Opendoors Pharma's top competitors are
Globally Centers,
Labo Cosprophar,
Brand Image,
Modumpharma,
Trust Data Privacy,
Tlc Worldwide,
@depth,
Hyeres Pharma,
Nutropharma,
Bepharma.
Opendoors Pharma's categories are Pharmaceutical Manufacturing
Opendoors Pharma's founding year is 2018
